The Ministry of Health has the right to put increased demands on the participants of the market of medical drugs in government procurement, said the head of social control and trade FAS Timothy Nizhegorodtsev. AMI edition, he explained that, despite the rigidity, these requirements are clear and contain the principles of fair competition.
So, Nizhegorodtsev said that in the preparation of the national immunization calendar as a vaccine against pneumococcal disease was selected drug "Prevenar-13" manufactured by Pfizer. However, FAS reacted to the statement competitor, Glaxosmithkline, the vaccine "Sinfloriks" also had the right to win the tender.
He also said that his office for six months to conduct research and concluded that both vaccines are comparable on key parameters. However, in regard to these three strains, they are not interchangeable.